Cargando…
Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967664/ https://www.ncbi.nlm.nih.gov/pubmed/35371438 http://dx.doi.org/10.1093/ckj/sfab260 |
| _version_ | 1784678879127928832 |
|---|---|
| author | Roca Oporto, F J Rocha, Jose L |
| author_facet | Roca Oporto, F J Rocha, Jose L |
| author_sort | Roca Oporto, F J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8967664 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89676642022-03-31 Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome Roca Oporto, F J Rocha, Jose L Clin Kidney J Letter to the Editor Oxford University Press 2021-12-09 /pmc/articles/PMC8967664/ /pubmed/35371438 http://dx.doi.org/10.1093/ckj/sfab260 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Roca Oporto, F J Rocha, Jose L Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome |
| title | Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome |
| title_full | Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome |
| title_fullStr | Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome |
| title_full_unstemmed | Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome |
| title_short | Raynaud's phenomenon triggered by the vasopressin V(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome |
| title_sort | raynaud's phenomenon triggered by the vasopressin v(2) receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and sjögren's syndrome |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967664/ https://www.ncbi.nlm.nih.gov/pubmed/35371438 http://dx.doi.org/10.1093/ckj/sfab260 |
| work_keys_str_mv | AT rocaoportofj raynaudsphenomenontriggeredbythevasopressinv2receptorantagonisttolvaptaninapatientwithautosomaldominantpolycystickidneydiseaseandsjogrenssyndrome AT rochajosel raynaudsphenomenontriggeredbythevasopressinv2receptorantagonisttolvaptaninapatientwithautosomaldominantpolycystickidneydiseaseandsjogrenssyndrome |